Skip to main content

Table 2 Clinical diagnosis and seroprevalence of anti-T. gondii IgG antibodies in 137 psychiatric patients.

From: Seroepidemiology of Toxoplasma gondiiinfection in psychiatric inpatients in a northern Mexican city

Clinical Diagnosis

ICD-10 diagnosis

Patients studied

Patients with anti-T. gondii antibodies

 
  

No.

%

No.

%

P value*

Schizophrenia

F20

38

27.7

10

26.3

0.005

Mental and behavioural disorders due to psychoactive substance use

F14, F18–19

25

18.2

4

16

0.21

Mental disorder

F06.2, F06.8–9

20

14.6

1

5

0.47

Mental retardation

F71–73

19

13.9

4

21.1

0.1

Mental and behavioural disorders due to use of alcohol

F10

14

10.2

2

14.3

0.38

Bipolar affective disorder

F31

6

4.4

1

16.7

0.44

Epilepsy

G40

4

3

0

0

0.69

Severe depressive episode

F32.2–3

3

2.2

1

33.3

0.25

Dementia in Alzheimer's disease with early onset

F00.0

2

1.5

2

100

0.009

Dissociative disorder

F44

1

0.7

0

0

0.91

Vascular dementia

F01

1

0.7

0

0

0.91

Somatoform disorder

F45

1

0.7

0

0

0.91

Obsessive-compulsive disorder

F42

1

0.7

0

0

0.91

Acute polymorphic psychotic disorder

F23.1

1

0.7

0

0

0.91

Schizoaffective disorder, mixed type

F25.2

1

0.7

0

0

0.91

All

 

137

100

25

18.2

0.02

  1. *As compared with 8.9% seroprevalence of anti-T. gondii IgG antibodies in controls (16/180).